logo

For the Inventor, By the Inventor

Santa Monica, CA, United States of America

Kite Pharma, Inc.


USPTO Granted Patents = 51



Trademarks = 21

Forward Citations = 92

Loading Chart...
Loading Chart...

62 inventors (with patents filed for the assignee):

goldMedal Stuart A Sievers (15 out of 17 patents)

silverMedal Adrian I Bot (11 out of 11 patents)

bronzeMedal Jed Wiltzius (11 out of 12 patents)

4.  Jed J W Wiltzius (7 out of 7 patents)

5.  Steven A Rosenberg (6 out of 149 patents)

6.  Ruben Alvarez Rodriguez (6 out of 7 patents)

7.  Jeffrey S Wiezorek (6 out of 7 patents)

8.  William Go (6 out of 7 patents)

9.  Rajul Jain (6 out of 7 patents)

10.  Jonathan Belk (5 out of 21 patents)

11.  John M Rossi (5 out of 5 patents)

12.  James Noble Kochenderfer (5 out of 30 patents)

13.  Peter Emtage (4 out of 15 patents)

14.  Gabrielle Romain (3 out of 3 patents)

15.  Sarah Wyman (3 out of 4 patents)


Core Competencies:
Chimeric Antigen Receptor
T Cell Therapy
Immune Cell Function
Antigen Binding Molecules
Prostate Cancer
CD70 Binding Molecules
Modified Receptors
GPC3 Binding Molecules
Diagnostic Methods
Chimeric Polypeptides
TGF-Beta Receptors
Tumor Microenvironment

51 patents:

1. 12736455 - Systems and methods for detecting suspended particles in fluids (2026-09-15),
2. D1147437 - Cassette rack (2026-09-08),
3. 12715925 - Methods of administering chimeric antigen receptor immunotherapy (2026-08-25),
4. 12709639 - METHODS OF ADMINISTERING CHIMERIC ANTIGEN RECEPTOR IMMUNOTHERAPY (2026-08-18),
5. 12630603 - Chimeric antigen receptor T cell therapy (2026-05-19),
6. 12600775 - Chimeric antigen receptor T cell therapy (2026-04-14),
7. 12583923 - CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE (2026-03-24),
8. 12551530 - IMMUNE CELL FUNCTION (2026-02-17),
9. 12540196 - GPC3 BINDING MOLECULES (2026-02-03),
10. 12480951 - METHODS AND COMPOSITIONS FOR T CELL THERAPY (2025-11-25),
11. D1102621 - Cassette rack (2025-11-18),
12. 12459979 - Modified chimeric antigen receptors and methods of use (2025-11-04),
13. 12458654 - Methods of conditioning patients for T cell therapy (2025-11-04),
14. 12454563 - Immune cell function (2025-10-28),
15. 12404305 - Chimeric polypeptides and uses thereof (2025-09-02),
Kite Pharma, Inc., based in Santa Monica, CA, specializes in the development of innovative chimeric antigen receptor (CAR) therapies for cancer treatment. The company focuses on harnessing the power of T cell therapy to enhance immune cell function, targeting specific antigens associated with various cancers, including prostate cancer. Kite Pharma's research encompasses advanced technologies such as modified receptors and antigen binding molecules, positioning the company at the forefront of immuno-oncology advancements.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Kite Pharma, Inc.
51 Patents

#12 in Santa Monica, CA

#1,618 in California

#6,879 in US

#13,766 in the World

Santa Monica, CA (US)
Santa Monica, CA, United States of America

Kite Pharma, Inc.

Forward Citations = 92

62 inventors:

goldMedal Stuart A Sievers (15 out of 17 patents)

silverMedal Adrian I Bot (11 out of 11 patents)

bronzeMedal Jed Wiltzius (11 out of 12 patents)

4.  Jed J W Wiltzius (7 out of 7 patents)

5.  Steven A Rosenberg (6 out of 149 patents)

Please report any incorrect information to [email protected]
Loading…